APA (7th ed.) Citation

RA, N., S, B., A, P., GS, P., S, P., R, S., . . . DC, M. (2025). Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD). ACS omega, 10(22), 22685. https://doi.org/10.1021/acsomega.4c11023

Chicago Style (17th ed.) Citation

RA, Ng, et al. "Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD)." ACS Omega 10, no. 22 (2025): 22685. https://doi.org/10.1021/acsomega.4c11023.

MLA (9th ed.) Citation

RA, Ng, et al. "Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD)." ACS Omega, vol. 10, no. 22, 2025, p. 22685, https://doi.org/10.1021/acsomega.4c11023.